Morgan Stanley raises Amgen stock price target on obesity drug potential

Morgan Stanley raises Amgen stock price target on obesity drug potential  Investing.com UK

Summary aggregated from Investing.com UK's public RSS feed. The full reporting belongs to Investing.com UK — please read it on their site.